$329 Million is the total value of Invus Financial Advisors, LLC's 8 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CPNG | Sell | Coupang Inccl a | $92,975,000 | -21.7% | 3,164,571 | -25.8% | 28.26% | -11.2% |
| RCUS | Sell | Arcus Biosciences Inc | $65,241,000 | +1.6% | 1,612,077 | -12.5% | 19.83% | +15.2% |
| TBLA | Sell | Taboola.com Ltd | $60,837,000 | -8.6% | 7,819,690 | -0.6% | 18.49% | +3.7% |
| OYST | Oyster Point Pharma Inc | $50,554,000 | +54.1% | 2,768,586 | 0.0% | 15.36% | +74.8% | |
| NVCR | Novocure Ltd | $26,344,000 | -35.4% | 350,884 | 0.0% | 8.01% | -26.7% | |
| New | IONQ Inc | $16,700,000 | – | 1,000,000 | +100.0% | 5.08% | – | |
| ORIC | Oric Pharmaceuticals Inc | $14,811,000 | -29.7% | 1,007,575 | 0.0% | 4.50% | -20.3% | |
| UBX | Unity Biotechnology Inc | $1,599,000 | -51.3% | 1,094,998 | 0.0% | 0.49% | -44.8% | |
| YEXT | Exit | Yext Inc | $0 | – | -2,146,785 | -100.0% | -6.92% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Arcus Biosciences Inc | 16 | Q3 2023 | 24.7% |
| Novocure Ltd | 16 | Q3 2023 | 25.4% |
| Oric Pharmaceuticals Inc | 14 | Q3 2023 | 14.3% |
| Oyster Point Pharma Inc | 13 | Q4 2022 | 44.5% |
| Coupang Inc | 11 | Q3 2023 | 51.6% |
| Taboola.com Ltd | 10 | Q3 2023 | 23.7% |
| Unity Biotechnology Inc | 9 | Q4 2021 | 8.0% |
| Yext Inc | 8 | Q3 2021 | 30.3% |
| IONQ Inc | 8 | Q3 2023 | 7.2% |
| Nu Hldgs Ltd | 6 | Q3 2023 | 25.4% |
View Invus Financial Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Invus Financial Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.